UPEXI INC
UPXINASDAQTrading Snapshot
- Day Range
- $1.14 – $1.18
- 52-Week Range
- $0.54 – $7.75
- Volume
- $2.01B
- Avg Volume
- $2.10B
- Shares Outstanding
- 73.5M
- Next Earnings
- Oct 28, 2026
Fundamentals Snapshot
- Annual Revenue
- $25M
- Last Q Revenue
- $3M
- P/E Ratio
- -0.3
- P/S Ratio
- 3.4x
- EPS (TTM)
- $-3.87
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +4.5%
Why Investors Own UPXI
- ✓High-growth profile — revenue up +47.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 61% gross margin and 7% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
UPEXI INC
UPXI
StockOtter · stockotter.spaceAbout UPEXI INC
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
UPEXI INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift UPXI price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
UPEXI INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.